rs587779065

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong

The NM_000251.3(MSH2):​c.1013G>A​(p.Gly338Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,120 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G338R) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

MSH2
NM_000251.3 missense

Scores

15
3
1

Clinical Significance

Pathogenic reviewed by expert panel P:3

Conservation

PhyloP100: 9.81
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PM1
In a helix (size 11) in uniprot entity MSH2_HUMAN there are 5 pathogenic changes around while only 1 benign (83%) in NM_000251.3
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr2-47416365-G-A is described in Lovd as [Pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.992
PP5
Variant 2-47416366-G-A is Pathogenic according to our data. Variant chr2-47416366-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 90504.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr2-47416366-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MSH2NM_000251.3 linkuse as main transcriptc.1013G>A p.Gly338Glu missense_variant 6/16 ENST00000233146.7 NP_000242.1 P43246-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MSH2ENST00000233146.7 linkuse as main transcriptc.1013G>A p.Gly338Glu missense_variant 6/161 NM_000251.3 ENSP00000233146.2 P43246-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.85e-7
AC:
1
AN:
1460120
Hom.:
0
Cov.:
29
AF XY:
0.00000138
AC XY:
1
AN XY:
726548
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.01e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Lynch-like syndrome Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingConstitutional Genetics Lab, Leon Berard Cancer CenterJul 01, 2019- -
Lynch syndrome Pathogenic:1
Pathogenic, reviewed by expert panelresearchInternational Society for Gastrointestinal Hereditary Tumours (InSiGHT)Sep 05, 2013Multifactorial likelihood analysis posterior probability >0.99 -
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsNov 24, 2020The p.G338E pathogenic mutation (also known as c.1013G>A), located in coding exon 6 of the MSH2 gene, results from a G to A substitution at nucleotide position 1013. The glycine at codon 338 is replaced by glutamic acid, an amino acid with similar properties. This variant was identified in a male proband who met Amsterdam I criteria for Lynch syndrome and was diagnosed with bladder cancer at the age of 57 as well as MSI-H colon cancer cancer at the of age 32 that demonstrated loss of both MSH2/MSH6 staining on immunohistochemistry (IHC) (Raskin L et al. Oncotarget, 2017 Nov;8:93450-93463). Based on an internal structural analysis, this variant is anticipated to result in a significant decrease in structural stability (Warren JJ et al. Mol Cell, 2007 May;26:579-92). Another alteration at the same codon, p.G338R (c.1012G>C), has been detected in individuals with family histories that met Amsterdam I/II criteria and/or had Lynch syndrome associated tumors that demonstrated loss of MSH2/MSH6 staining on IHC (Ambry internal data; Moline J et al, Gynecol. Oncol. 2013 Jul; 130(1):121-6; Pearlman R et al. J. Med. Genet., 2019 Jul;56:462-470). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.59
D
BayesDel_noAF
Pathogenic
0.61
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.94
D;.;.;.
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.97
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D;D;D;D
M_CAP
Pathogenic
0.82
D
MetaRNN
Pathogenic
0.99
D;D;D;D
MetaSVM
Pathogenic
0.96
D
MutationAssessor
Pathogenic
3.5
H;.;.;.
PrimateAI
Pathogenic
0.84
D
PROVEAN
Pathogenic
-7.8
D;D;.;D
REVEL
Pathogenic
0.96
Sift
Pathogenic
0.0
D;D;.;D
Sift4G
Uncertain
0.0020
D;D;.;D
Polyphen
1.0
D;.;.;D
Vest4
0.99
MutPred
0.93
Loss of MoRF binding (P = 0.0283);.;Loss of MoRF binding (P = 0.0283);Loss of MoRF binding (P = 0.0283);
MVP
0.99
MPC
0.032
ClinPred
1.0
D
GERP RS
5.6
Varity_R
0.99
gMVP
0.89

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs587779065; hg19: chr2-47643505; COSMIC: COSV105086125; API